Aveanna Healthcare Holdings Inc. $AVAH Shares Sold by Jacobs Levy Equity Management Inc.

Key Points

• Jacobs Levy Equity Management Inc. reduced its stake in Aveanna Healthcare by 19.1%, owning 431,138 shares valued at approximately $2.34 million after selling 102,058 shares in the first quarter.
• Institutional investors hold 87.96% of Aveanna Healthcare's stock, with notable increases from firms such as Millennium Management and Mackenzie Financial Corp.
• Analyst ratings for Aveanna Healthcare have mixed sentiments, with target prices ranging from $5.00 to $9.50, reflecting a consensus average rating of "Moderate Buy."

Jacobs Levy Equity Management Inc. reduced its position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 19.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 431,138 shares of the company's stock after selling 102,058 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 0.22% of Aveanna Healthcare worth $2,337,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Banque Transatlantique SA purchased a new position in Aveanna Healthcare during the first quarter worth about $25,000. BNP Paribas Financial Markets acquired a new position in Aveanna Healthcare during the fourth quarter worth about $35,000. Tower Research Capital LLC TRC grew its position in Aveanna Healthcare by 662.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after buying an additional 6,854 shares during the period. Jump Financial LLC acquired a new position in Aveanna Healthcare during the first quarter worth about $59,000. Finally, ProShare Advisors LLC acquired a new position in Aveanna Healthcare during the fourth quarter worth about $67,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have weighed in on AVAH shares. Barclays upgraded shares of Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $5.50 to $9.50 in a research report on Tuesday, August 19th. UBS Group upgraded shares of Aveanna Healthcare from a "sell" rating to a "neutral" rating and upped their target price for the stock from $6.75 to $8.00 in a research report on Tuesday, August 19th. Raymond James Financial upgraded shares of Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 target price on the stock in a research report on Monday, August 11th. Wall Street Zen upgraded shares of Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Finally, Jefferies Financial Group upgraded shares of Aveanna Healthcare from a "hold" rating to a "buy" rating and lowered their target price for the stock from $6.25 to $6.00 in a research report on Monday, July 21st. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $7.50.

Aveanna Healthcare Trading Up 0.2%

Shares of AVAH stock traded up $0.02 during trading hours on Friday, hitting $8.44. The company's stock had a trading volume of 1,129,900 shares, compared to its average volume of 1,272,597. The business has a fifty day moving average of $5.94 and a 200-day moving average of $5.31. The stock has a market cap of $1.76 billion, a price-to-earnings ratio of 105.50 and a beta of 2.04. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.67 and a twelve month high of $8.54.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.